Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Xoom Corp (XOOM) Acquired By PayPal, Investors Think Story Not Over Yet; Is It A Good Time To Buy The Stock?

Page 1 of 2

PayPal has announced that it is acquiring Xoom Corp (NASDAQ:XOOM), a San Francisco-based money transfer company for $890 million, or $25 per share. PayPal’s acquisition of Xoom Corp (NASDAQ:XOOM) comes just weeks before its expected spin-off from eBay. PayPal’s President Dan Schulman said that his company envisions international expansions to facilitate people around the world in international money transfers. Xoom’s presence in 37 countries will help PayPal in those plans. After the acquisition announcement, Xoom shares surged 25% in after-hours trading to $25.55, pushing Xoom Corp (NASDAQ:XOOM) up by 43.33% over the last three months. Most interestingly, investors are clearly betting on a better offer for Xoom coming along and a resultant bidding war between PayPal and the new entrant(s), judging by the shares pushing past PayPal’s offering rate. The company reported a loss of $1.3 million in the first quarter. However, Xoom Corp (NASDAQ:XOOM) reported $44.4 million in revenue for the quarter, beating the Zack Consensus Estimate of $43.9 million. Let’s have a detailed look at the current hedge funds sentiment and latest insider transactions for the money transfer company to get a more holistic and clear picture.


12 of the hedge funds tracked by Insider Monkey held long positions in Xoom by the end of the first quarter of 2015, whereas 13 hedge funds were bullish on the company three months prior, which shows a decrease of 8% in the hedge funds’ holdings in the company. The total value of hedge funds’ investment in Xoom was valued at $104 million on March 31, whereas the total ownership value was $169 million on December 31, which shows a large decrease in hedge funds’ ownership, even factoring in that shares dipped by 16% during the first quarter.

We at Insider Monkey strongly believe in the importance and value of tracking hedge funds’ positions in companies because hedge funds spend large amounts of resources, time, and money to decide their bets on companies. Our experts analyzed the historical stock picks of small-cap companies made by hedge funds and found out that the funds performed far better betting on these companies than they did on large-cap stocks, which is where most of their money is invested and why their performances as a whole have been poor for a number of years. A portfolio of the 15 most popular small-cap stocks among funds outperformed the S&P 500 Total Return Index by 95 basis points per month between 1999 and 2012 in backtesting. The exceptional results of this strategy got even better in forward testing after the strategy went live at the end of August 2012, returning more than 135% and beating the market by more than 80 percentage points since then, and by 4.6 percentage points in the first quarter of this year. (see more details on this).

Our experts take both hedge funds’ activity and insider transactions into account while making investment decisions regarding a company. As for the insider transactions for Xoom, John Kunze, CEO of Xoom, sold 18,750 shares of the company at $18.76 per share on May 19. He also sold 18,750 shares of the company at $17.84 on May 12. There were no insider purchases recorded for the company in 2015.

Let’s now have a detailed look at the hedge funds’ activity around Xoom.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!